Table 2.
Comparisons of completers Vs those who were lost for follow up.
| Variables | Completed follow-up (n=35) | Lost follow-up (n=11) | t/X2 | p value |
|---|---|---|---|---|
| Risperidone# | 22(73.3) | 8(26.7) | 0.359 | 0.549 |
| Aripiprazole# | 13(81.2) | 3(18.8) | ||
| Baseline* PANSS | 71.55(28.64) | 74.37(22.49) | 37.756 | 0.481 |
| Female# | 14(40) | 2(18.2) | 1.756 | 0.185 |
| Age* | 29.09(7.56) | 34.91(7.48) | -2.23 | 0.031 |
| Illness duration in months* | 41.57(38.05) | 65.45(59.42) | -1.576 | 0.122 |
| Rural domicile# | 25(71.4) | 4(36.4) | 4.417 | 0.036 |
| Drug naïve# | 19(54.3) | 6(54.5) | 0.000 | 0.988 |
*All values in cells are mean (SD) #All values in cells are mean (%).